+3S
A biomedical high-tech enterprise mainly engaged in antitoxin and antiserum. .
Launch date
Employees
Qingpu District China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
CNY50.0m | Post IPO Equity | ||
N/A | N/A | IPO | |
CNY50.0m | Post IPO Equity | ||
Total Funding | - |
Date | Investors | Amount | Round |
---|---|---|---|
CNY50.0m | Post IPO Equity | ||
N/A | N/A | IPO | |
CNY50.0m | Post IPO Equity | ||
Total Funding | - |